<DOC>
	<DOCNO>NCT01127477</DOCNO>
	<brief_summary>The study shall evaluate volume effect safety 6 % hydroxyethyl starch 130/0.4 restoration maintenance hemodynamics investigational period patient undergo major elective surgery . Up 50 mL 6 % hydroxyethyl starch/kg body weight administered start surgery two hour end surgery . The study hypothesis 6 % hydroxyethyl starch 130/0.4 reliable volume effect safely administer dose limit .</brief_summary>
	<brief_title>Study Obtain Volume Effect Safety Data 6 % Hydroxyethyl Starch 130/0.4 Pediatric Adult Patients Undergoing Major Elective Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hypovolemia</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Patients undergo major elective surgery Adults patient ( ≥20 year age ) : expect blood loss ≥ 1000mL Pediatric patient ( &lt; 20 year age ) : expect blood loss ≥ 15 mL/kg Adult patient : Routine measurement Central Venous Pressure ( CVP ) Known suspect allergy hydroxyethyl starch , include ingredient ( inclusive corn ) relate drug ASA classification ≥ IV Adult patient : renal failure oliguria ( &lt; 400 mL urin /24hours ) anuria Pediatric patient : renal failure oliguria anuria related hypovolemia Known bleeding disorder Other contraindication accord current SmPC Voluven 6 % solution infusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Hypovolemia , surgical blood loss</keyword>
</DOC>